Joint workshop with representatives from patients', consumers' and healthcare professionals' organisations: Regulatory and methodological standards to improve benefit-risk evaluation of medicines

This is a joint workshop with representatives from patients', consumers' and healthcare professionals' organisations. The workshop will provide an overview of current international benefit-risk initiatives as well as on the outcomes of recent EMA/CHMP benefit-risk projects. The on-going initiatives to capture patient values and preferences in benefit-risk and to translate benefit-risk regulatory decisions into product information will also be presented. Participants will have an opportunity to discuss, through practical examples, how benefit-risk models in general could support healthcare professionals and patients in the therapeutic decision-making process.Registration by invitation only.